title: Lamivudine in the last 4 weeks of pregnancy to prevent perinatal transmission in highly viremic chronic hepatitis B patients.
authors.forename: A B
authors.initials: AB
authors.lastname: van Nunen
authors.forename: R A
authors.initials: RA
authors.lastname: de Man
authors.forename: R A
authors.initials: RA
authors.lastname: Heijtink
authors.forename: H G
authors.initials: HG
authors.lastname: Niesters
authors.forename: S W
authors.initials: SW
authors.lastname: Schalm
mesh_terms: D005260:Female; D019694:Hepatitis B, Chronic / Q000517:prevention & control*; D006801:Humans; D018445:Infectious Disease Transmission, Vertical / Q000517:prevention & control*; D019259:Lamivudine / Q000627:therapeutic use*; D011247:Pregnancy; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use*; D014766:Viremia / Q000517:prevention & control* / Q000635:transmission*
chemical_list: D018894:Reverse Transcriptase Inhibitors; D019259:Lamivudine